Follow
HADI M. YASSINE
HADI M. YASSINE
Section Head of Research, Associate Professor of Infectious Diseases, IBC chair, Qatar University
Verified email at QU.edu.qa
Title
Cited by
Cited by
Year
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B. 1.1. 7 and B. 1.351 Variants
LJ Abu-Raddad, H Chemaitelly, AA Butt
New England Journal of Medicine 385 (2), 187-189, 2021
11212021
Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar
H Chemaitelly, P Tang, MR Hasan, S AlMukdad, HM Yassine, ...
New England Journal of Medicine 385 (24), e83, 2021
9132021
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
M Kanekiyo, CJ Wei, HM Yassine, PM McTamney, JC Boyington, ...
Nature 499 (7456), 102-106, 2013
8992013
Pre-fusion structure of a human coronavirus spike protein
RN Kirchdoerfer, CA Cottrell, N Wang, J Pallesen, HM Yassine, HL Turner, ...
Nature 531 (7592), 118-121, 2016
8602016
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
HM Yassine, JC Boyington, PM McTamney, CJ Wei, M Kanekiyo, ...
Nature medicine 21 (9), 1065-1070, 2015
6872015
Effects of previous infection and vaccination on symptomatic omicron infections
HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ...
New England Journal of Medicine 387 (1), 21-34, 2022
5102022
Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms
MK Smatti, FS Cyprian, GK Nasrallah, AA Al Thani, RO Almishal, ...
Viruses 11 (8), 762, 2019
5032019
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
P Tang, MR Hasan, H Chemaitelly, HM Yassine, FM Benslimane, ...
Nature medicine 27 (12), 2136-2143, 2021
4782021
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
Q Fernandes, VP Inchakalody, M Merhi, S Mestiri, N Taib, ...
Annals of medicine 54 (1), 524-540, 2022
4532022
Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2
N Younes, DW Al-Sadeq, H Al-Jighefee, S Younes, O Al-Jamal, HI Daas, ...
Viruses 12 (6), 582, 2020
4522020
Protection against the Omicron variant from previous SARS-CoV-2 infection
HN Altarawneh, H Chemaitelly, MR Hasan, HH Ayoub, S Qassim, ...
New England Journal of Medicine 386 (13), 1288-1290, 2022
4362022
mRNA-1273 COVID-19 vaccine effectiveness against the B. 1.1. 7 and B. 1.351 variants and severe COVID-19 disease in Qatar
H Chemaitelly, HM Yassine, FM Benslimane, HA Al Khatib, P Tang, ...
Nature medicine 27 (9), 1614-1621, 2021
4212021
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
JO Ngwuta, M Chen, K Modjarrad, MG Joyce, M Kanekiyo, A Kumar, ...
Science translational medicine 7 (309), 309ra162-309ra162, 2015
4032015
Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar
LJ Abu-Raddad, H Chemaitelly, HH Ayoub, S AlMukdad, HM Yassine, ...
New England Journal of Medicine 386 (19), 1804-1816, 2022
3952022
Evaluation of candidate vaccine approaches for MERS-CoV
L Wang, W Shi, MG Joyce, K Modjarrad, Y Zhang, K Leung, CR Lees, ...
Nature communications 6 (1), 7712, 2015
3422015
Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses
MG Joyce, AK Wheatley, PV Thomas, GY Chuang, C Soto, RT Bailer, ...
Cell 166 (3), 609-623, 2016
3292016
Structural and genetic basis for development of broadly neutralizing influenza antibodies
D Lingwood, PM McTamney, HM Yassine, JRR Whittle, X Guo, ...
Nature 489 (7417), 566-570, 2012
3022012
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
M Kanekiyo, MG Joyce, RA Gillespie, JR Gallagher, SF Andrews, ...
Nature immunology 20 (3), 362-372, 2019
2682019
Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting
Clinical Infectious Diseases, 2020
244*2020
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants in Qatar
H Chemaitelly, HH Ayoub, S AlMukdad, P Coyle, P Tang, HM Yassine, ...
Nature communications 13 (1), 3082, 2022
2402022
The system can't perform the operation now. Try again later.
Articles 1–20